（3S-反式）-3-\ [（1,3-苯并二氧戊环-5-氧基）甲基]-4-（4-氟苯基）哌啶盐酸盐半水合物

产品名称：

110429-35-1
Paroxetine for system suitability
Paroxetine Hydrochloride Hemihydrate
(3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate
帕罗西汀
帕罗西汀盐酸盐半水合物
（3S-反式）-3-\ [（1,3-苯并二氧戊环-5-氧基）甲基]-4-（4-氟苯基）哌啶盐酸盐半水合物

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

盐酸帕罗西汀半水化合物是选择性 5-羟色胺再摄取抑制剂 (SSRI) 中作用最强、选择性最强的一种；抗抑郁药

包装

Unit quantity: 0.02 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₉H₂₀FNO₃ · HCl · .5 H₂O
分子量	374.83
MDL编号	MFCD03658863
PubChem化学物质编号	329831063
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
SMILES string	O.Cl[H].Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3
InChI	1S/C19H20FNO3.ClH.H2O/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;;/h1-6,9,14,17,21H,7-8,10-12H2;1H;1H2/t14-,17-;;/m0../s1
InChI key	QRQSGFFISBKLMZ-YHOFXEKLSA-N
Gene Information	human ... SLC6A4(6532)

安全信息

象形图
警示用语：	Warning
危险声明	H302 - H411
预防措施声明	P273 - P301 + P312 + P330
危险分类	Acute Tox. 4 Oral - Aquatic Chronic 2
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable